SARAH O-CONNOR

Profile

First Name

: SARAH

Middle Name

:

Last Name

: O-CONNOR

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$5,000,001 - $25,000,000 
Equity 
2017-10-24 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-01 
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$5,000,001 - $25,000,000 
Equity 
2015-01-29 
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$5,000,001 - $25,000,000 
Equity 
2014-11-25